{"name":"SI-BONE","slug":"si-bone","ticker":"SIBN","exchange":"NASDAQ","domain":"si-bone.com","description":"SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined tit","hq":"Santa Clara, CA","founded":0,"employees":"376","ceo":"Laura Francis","sector":"Medical Devices","stockPrice":14.88,"stockChange":0.72,"stockChangePercent":5.08,"marketCap":"$660M","metrics":{"revenue":206223008,"revenueGrowth":11.2,"grossMargin":79.6,"rdSpend":17448000,"netIncome":-18904000,"cash":144683008,"dividendYield":0,"peRatio":-42.2,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":".75% bupivacaine","genericName":".75% bupivacaine","slug":"75-bupivacaine","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":".75% bupivacaine","genericName":".75% bupivacaine","slug":"75-bupivacaine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"SI-BONE Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"SI-BONE reported fourth quarter and full year 2023 financial results, with revenue of $53.8 million and $193.4 million, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-09-26","type":"deal","headline":"SI-BONE Announces Collaboration with Orthofix to Develop and Commercialize Minimally Invasive Spinal Solutions","summary":"SI-BONE announced a collaboration with Orthofix to develop and commercialize minimally invasive spinal solutions for patients with complex spinal disorders.","drugName":"","sentiment":"positive"},{"date":"2023-06-06","type":"regulatory","headline":"SI-BONE Receives FDA 510(k) Clearance for iFuse-3D Implant System","summary":"SI-BONE received FDA 510(k) clearance for its iFuse-3D Implant System, a minimally invasive surgical solution for patients with complex spinal disorders.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQbE9PUmx5QzYxNXZsb1IweXh1a3RvRVhrVS1oTWdveWdfd2tVRVI5S0NPZ1I3VF91NTMyazF1SVpVbVdyQTVxMkdjYko3UTdNcFY1Yzd0Y3RuajBzTzBwblZIX3pXNW5xMU5CdjV2dzVpSWl1RGtNclBoWFdVSDdlT3ZPYmNJTXd1S0pQSk12Vkh1NmVOQkRpWVM1SXVZQlRzVS0zT1dfVFo4ZWVpT3kzdVlkdzVpWU90YzdhRUI2RWs?oc=5","date":"2026-03-31","type":"pipeline","source":"AD HOC NEWS","summary":"SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape - AD HOC NEWS","headline":"SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVVFIOHloLTQ3Y2VoS1FKMld1YzdpRmtHeEM0dlZDV3N5UjlfeHo5MFlycUZxRW9VWlpHYUEwbzNiNjBMd1MyUklXWFVxMUpxV1pjNklnSWFuLTF1RG1PTVpWQjE5TVBkUjZEa0hNaEl4cjAtZ29kSWZfWEthem5HSnpZM01iMU5HcEhELUFlQ0MzeDVfRE9aYUlINmdMSWVYZDExV212Y2syWWM?oc=5","date":"2026-03-30","type":"pipeline","source":"MarketBeat","summary":"SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest - MarketBeat","headline":"SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNX1I1aVVNdjR3RUxHVFRzNWs4N1gxM1J0T2NSOHJDQ1RqUnZvWUR4Zzhtd2o3Ulg5MGV3MnhyRVFfRTRFT0o3NTFkd1BueTA2M0U3V2xmb2NNVHJ6U3hmSGtZTHhPU1BnYWo1LXEtS0pRU3hIclRMQktkUHlaazZfUkRqa0lfZEV3WWRIdmV6cTA5dw?oc=5","date":"2026-03-12","type":"pipeline","source":"Stock Titan","summary":"[144] SI-BONE, Inc. SEC Filing - Stock Titan","headline":"[144] SI-BONE, Inc. SEC Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOdktBZW5WZ1ZXV05JUGFxMEZXQXlBbU1NVXZEakRDUnQ3dy12Nk9LR3RRQ3JVTFNNZzQ3WkZmWWU3bVY1V0haOE11a1NuT3lhRXZnNUlHZUVpSDBBZHVtdlh1aXdON3E1V0I3ZTU2VzIxR0JaWldMdE4wX012djMyOTZSLXNGQzE2VGVqY0FjT3Z3OVdlNGFuNHVR?oc=5","date":"2026-02-24","type":"pipeline","source":"BioSpace","summary":"Smith+Nephew signs distribution agreement with SI-BONE - BioSpace","headline":"Smith+Nephew signs distribution agreement with SI-BONE","sentiment":"neutral"},{"date":"2026-02-24","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQR2hUVS05RVJFblNEMDA0aGJyc1FWeG8tLTRkdUVCXzFDSkpUNlJFVGd1alNYbjdaakx1aTB3UGd2M2hoY3BCWjhJbExXSGZCVDMyWjNJWV9qbzdlcEJXb3hqSmlxbmoxZm0zNVJ2bVl3NnpIbHRRLWM1eVZYQV9fcWxZUnVGY3RMUVl6Nk5VOVM3Z1pYRHRmWHl2eTlmRUk4c3FVN0QzVUZwdjJFLWZZal94SFRaVHlsblF4ZkMydW1rRjJ5TXFmQUx6bHF2a0hGenI4ZUd2UmUzMzJoeXhGUURHcW9SOVdPa2hueTIyYl9xcVE?oc=5","date":"2026-02-02","type":"earnings","source":"GlobeNewswire","summary":"SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026 - GlobeNewswire","headline":"SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQenk0NjY1SGZQSmdQRUVaNGFkWW1keTlDeE1BUWdNdllVZnNkeVJha1diVkZzRjRxR2lXc3dNNy1HQ3RSbTRmSzlCREROd252Mk1DVDZIWE16cnI3SnNJRmt1UHpPM2RKZF9CZWZjOVhKcUdTSkZHZHBkN3BqSnY4ZA?oc=5","date":"2025-12-17","type":"pipeline","source":"Yahoo Finance","summary":"SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham - Yahoo Finance","headline":"SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNV0VzMzdHTEZ2VkEtTVF5QU56OWc1ZmFoczFwMlFVLWpUMWVMUUNMYTkwYzhXYVFFbjRLNmJlUkZIVTNCWVFjTUZRTktkMUgwV0JhXzlrNWV6RmdTTkJDakpVMVp0QXEtM3JMMUFiU1pMNWZTRVUzNmpZQlZFOThZWE9HSS0zMklyLVE?oc=5","date":"2023-10-25","type":"pipeline","source":"ERP Today","summary":"Salesforce unveils Life Sciences Cloud for pharma organizations - ERP Today","headline":"Salesforce unveils Life Sciences Cloud for pharma organizations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zMTEwS1FZR3hrVlUzUE8yd3dRUjdwcVAtb2NfQ21PN3hyeFRueW9tTGo1WGNjMmdpemxHVEUzVUJMQlRJTEhNeUlqZjhhNm5sakNTWmpscE51T2FYRFdabjdMcUVtMmRkS2FvN2xnVXowaF9QWGQ3Nl9RTQ?oc=5","date":"2022-12-27","type":"regulatory","source":"MassDevice","summary":"Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant - MassDevice","headline":"Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNeGEyaHNlRTg3bTR0eTh5Wll3OGdJRXkzREF1R21OX3VyTWdVMkMxMllWMGtILXZjeWN0WkxJRmZhbTRqNjU4bDZsYTRIcDgxMHVKQU9xeWQ4VUVHMktoeTd6UmFfVlYxV042blZJM0JFcE5XM3dMNTJjTzYzZ0NmZ0tVMnBTd2hFNHFBeHNqeE1YZU82Q1c3TGVjN0hWMWJUWk5SZ2VLWmxaSVFfdmJIX2NTcUNra1JNTFVwYnF0VDNlel92RjRrWnI4LXpWVVQyQTIwcElHdjNjX3VGUDcxMXZ6c1VIUnNiVE5lbDk1NkMtaUZJQlNGMi11RTZVVno2QU9OU3VkaHZPc19qS0MzNHNuVWpEZ0tLelhn?oc=5","date":"2022-05-31","type":"regulatory","source":"GlobeNewswire","summary":"SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse - GlobeNewswire","headline":"SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWGNWLXVJNjgyRVNCdjR5UldnX2ZHR21Yd0FyaURKczcwOHYyaEhJWFo5WFUzbmM1akRFQzRlSGdaSW1rUmRJX2tZU05McTBmQmZ1TlZMR2RwejRWMEsxS0I5UnFlXzZIQURHTWY3Y3d6R3VPWXg0azUxWkpfQzk4SQ?oc=5","date":"2021-01-07","type":"pipeline","source":"MassDevice","summary":"Laura Francis to move up to CEO spot at Si-Bone - MassDevice","headline":"Laura Francis to move up to CEO spot at Si-Bone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOXzVCQURDREhEb0lyb0g4QUlhVkJ1ODZ2SDgxRF9RbTduMTZ1Ty1PaVJiaTJiOC1wbW9oVFpEaFBrR2liX1l0QUFvNndDMllaZmZIb0R5UjFfbTVyemVneFA0NFFCMzRYM2JISUVSaEhfTFdjSWUtWHFwOXc2TnozVzcyMWhsM0NnV1F0Z3RWUTE3YjZ5TDRCVWU3N0hNTC1MQ19uLVJkSHpPZmdnLWtJcldCem5mMVdqNUlHc1FWLXBzMi1FUjg3TlQ5MS1fV3Z3OUo5SG1EbE8yUQ?oc=5","date":"2019-02-04","type":"pipeline","source":"GlobeNewswire","summary":"SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse - GlobeNewswire","headline":"SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBpaUJIemREUnlkTE5IRkN1ZU9TY0Uzb09hakdfQ205ZTRidThnemM2QVh0TEFRZGRaVG43VVVES3d1cUpZNnV0VzNESldrc3dxUzlrU1FRNVQxRVVBcHpfXw?oc=5","date":"2018-10-22","type":"pipeline","source":"MassDevice","summary":"Si-Bone closes $124m IPO - MassDevice","headline":"Si-Bone closes $124m IPO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Zimmer Biomet","Medtronic","Stryker"],"therapeuticFocus":["Orthopedic","Spinal Disorders"],"financials":{"source":"sec_edgar+yahoo","revenue":67301000,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":67301000,"period":"2019-12-31"},{"value":55380000,"period":"2018-12-31"},{"value":55380000,"period":"2018-12-31"},{"value":47983000,"period":"2017-12-31"}],"grossProfit":159879000,"grossProfitHistory":[{"period":"2025-12-31","value":159879000},{"period":"2024-12-31","value":132121000},{"period":"2023-12-31","value":109420000},{"period":"2022-12-31","value":90704000}],"rdSpend":17448000,"rdSpendHistory":[{"period":"2025-12-31","value":17448000},{"period":"2024-12-31","value":16560000},{"period":"2023-12-31","value":15028000},{"period":"2022-12-31","value":13627000}],"sgaSpend":164761000,"operatingIncome":-22330000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-22330000},{"period":"2024-12-31","value":-35248000},{"period":"2023-12-31","value":-46931000},{"period":"2022-12-31","value":-59609000}],"netIncome":-18904000,"netIncomeHistory":[{"period":"2025-12-31","value":-18904000},{"period":"2024-12-31","value":-30913000},{"period":"2023-12-31","value":-43336000},{"period":"2022-12-31","value":-61256000}],"eps":-0.44,"epsHistory":[{"period":"2025-12-31","value":-0.44},{"period":"2024-12-31","value":-0.75},{"period":"2023-12-31","value":-1.13},{"period":"2022-12-31","value":-1.79}],"cash":42240000,"cashHistory":[{"period":"2025-12-31","value":42240000},{"period":"2024-12-31","value":34948000},{"period":"2023-12-31","value":33271000},{"period":"2022-12-31","value":20717000}],"totalAssets":238555000,"totalLiabilities":61023000,"totalDebt":36688000,"equity":177532000,"operatingCashflow":-675000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-675000},{"period":"2024-12-31","value":-12425000},{"period":"2023-12-31","value":-18713000},{"period":"2022-12-31","value":-41655000}],"capex":-8414000,"capexHistory":[{"period":"2025-12-31","value":-8414000},{"period":"2024-12-31","value":-10497000},{"period":"2023-12-31","value":-7799000},{"period":"2022-12-31","value":-9507000}],"freeCashflow":-9089000,"dividendsPaid":null,"buybacks":null,"employees":376,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":42631000,"ebit":-1014000,"ebitda":624000,"period":"2025-12-31","revenue":56349000,"epsBasic":-0.04,"netIncome":-1644000,"rdExpense":4363000,"epsDiluted":-0.04,"grossProfit":44531000,"operatingIncome":-2463000},{"sga":39987000,"ebit":-3896000,"ebitda":-2410000,"period":"2025-09-30","revenue":48656000,"epsBasic":-0.11,"netIncome":-4566000,"rdExpense":4242000,"epsDiluted":-0.11,"grossProfit":38846000,"operatingIncome":-5383000},{"sga":41502000,"ebit":-5486000,"ebitda":-4118000,"period":"2025-06-30","revenue":48630000,"epsBasic":-0.14,"netIncome":-6152000,"rdExpense":4309000,"epsDiluted":-0.14,"grossProfit":38807000,"operatingIncome":-7004000},{"sga":40641000,"ebit":-5880000,"ebitda":-4602000,"period":"2025-03-31","revenue":47290000,"epsBasic":-0.15,"netIncome":-6542000,"rdExpense":4534000,"epsDiluted":-0.15,"grossProfit":37695000,"operatingIncome":-7480000},{"sga":40401000,"ebit":-3702000,"ebitda":-2489000,"period":"2024-12-31","revenue":49002000,"epsBasic":-0.11,"netIncome":-4495000,"rdExpense":3870000,"epsDiluted":-0.11,"grossProfit":38777000,"operatingIncome":-5494000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":14.88,"previousClose":14.16,"fiftyTwoWeekHigh":21.89,"fiftyTwoWeekLow":11.48,"fiftyTwoWeekRange":"11.48 - 21.89","fiftyDayAverage":13.3,"twoHundredDayAverage":15.89,"beta":0.67,"enterpriseValue":526249856,"forwardPE":-42.2,"priceToBook":3.66,"priceToSales":3.2,"enterpriseToRevenue":2.55,"enterpriseToEbitda":-38.04,"pegRatio":0,"ebitda":-13834000,"ebitdaMargin":-6.7,"freeCashflow":-2652125,"operatingCashflow":1874000,"totalDebt":42947000,"debtToEquity":24,"currentRatio":9.99,"returnOnAssets":-5.3,"returnOnEquity":-9.6,"analystRating":"1.4 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":9,"targetMeanPrice":23.33,"targetHighPrice":32,"targetLowPrice":16,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":3.3,"institutionHeldPercent":102.8,"sharesOutstanding":44349283,"floatShares":42868017,"sharesShort":4537455,"shortRatio":6.96,"shortPercentOfFloat":10.3,"epsTrailing":-0.39,"epsForward":-0.35,"revenuePerShare":4.75,"bookValue":4.07,"officers":[{"age":69,"name":"Mr. Jeffrey W. Dunn","title":"Executive Chairman"},{"age":58,"name":"Ms. Laura A. Francis MBA","title":"CEO & Director"},{"age":44,"name":"Mr. Anshul  Maheshwari","title":"COO & CFO"},{"age":46,"name":"Mr. Michael A. Pisetsky J.D.","title":"Chief Business & Legal Affairs Officer, Secretary and General Counsel"},{"age":65,"name":"Mr. Anthony J. Recupero","title":"Advisor"},{"age":57,"name":"Dr. Scott A. Yerby Ph.D.","title":"Senior VP of Engineering & CTO"},{"age":null,"name":"Mr. Saqib  Iqbal","title":"Vice President of Financial Planning & Analysis and Investor Relations"},{"age":null,"name":"Mr. Ian  Bailey","title":"Vice President of Product & Marketing"}],"industry":"Medical Devices","irWebsite":"","website":"https://si-bone.com","phone":"408 207 0700"}}